Skip to content
Ranked #68Desk pick
Hims & Hers

People who want a familiar consumer-brand app experience and don't need tirzepatide.

semaglutide
$199/mo
tirzepatide
Not confirmed for Hims & Hers.

FDAWarning letter issued to Hims & Hers Health, Inc. dba Hims in September 2025. See the FDA warning-letter database.

Before enrolling

Tirzepatide pricing inconsistently disclosed

vs
Ranked #93
NiceRx

Patients seeking batch-tested compounded GLP-1 with transparent entity disclosure.

semaglutide
$199/mo
tirzepatide
$299/mo
Before enrolling

New York was dropped from the service area since our last read, with no notice anywhere on the site; also unavailable in Alaska, Mississippi, New Jersey and Kansas

Our review of Hims & Hers gives it 79/100 (C+), while our review of NiceRx gives it 78/100 (C+). The score breakdown shows where each provider does better.

Desk Score, dimension by dimension

Same six measured dimensions for both. The green bar marks the stronger score. See the methodology.

Hims & Hers

79/100

C+

Overall

NiceRx

78/100

C+

Price transparency

74
78

State access

94
78

Molecule range

74
66

Onboarding speed

80
78

Support responsiveness

74
80

Licensing & trust

76
93

The spec sheet

Check the billing terms before comparing the figures. Our guide to paying for GLP-1 care without insurance explains how medication charges, membership fees and prepaid terms affect what you owe.

FieldHims & HersNiceRx
Semaglutide$199/mo
Full plan terms

$199/mo

$199/mo
Full plan terms

$199/mo month-to-month (compounded); $99 for the first month

TirzepatideNot confirmed for Hims & Hers.$299/mo
Full plan terms

$299/mo month-to-month (compounded); $199 for the first month

CoverageAll 50 states45 states
Brand-nameNot confirmed hereNot confirmed here
Oral optionNot confirmed hereNot confirmed here
Best forPeople who want a familiar consumer-brand app experience and don't need tirzepatide.Patients seeking batch-tested compounded GLP-1 with transparent entity disclosure.
Desk Score79/100C+78/100C+

The verdict

Desk pick — Hims & Hers

Hims & Hers has the higher Desk Score, but NiceRx may be a better fit if it covers your state, offers the prescribed product or has billing terms that work better for you.

Choose Hims & Hers if…

People who want a familiar consumer-brand app experience and don't need tirzepatide.

$199/mo sema · All 50 states

FDAWarning letter issued to Hims & Hers Health, Inc. dba Hims in September 2025. See the FDA warning-letter database.

Choose NiceRx if…

Patients seeking batch-tested compounded GLP-1 with transparent entity disclosure.

$199/mo sema · $299/mo tirz · 45 states

Assume any provider we list may compensate us. We may earn a referral commission at no extra cost to you, and compensation does not change the Desk Score.

Also here

CoreAge Rx leads the whole ranking at 94/100

Whichever of these two you lean toward, our #1-rated provider outscores them both. Both compounded injections with dose-independent advertised rates. The $79 and $129 monthly equivalents require a year paid in full; confirm the total charge and refund terms.

More head-to-heads

Or see the full comparison hub and the complete ranking.

Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.